Detection of prostate specific antigen in breast tumors
โ Scribed by H. He; E.P. Diamandis; D.J.A. Sutherland
- Publisher
- Elsevier Science
- Year
- 1994
- Tongue
- English
- Weight
- 124 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0009-9120
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Prostate-specific antigen (PSA) is a glycoprotein produced by the epithelial cells of the prostate. PSA is currently used clinically to diagnose and monitor prostate carcinoma. In previous work we have demonstrated that 30% of breast tumors and, more rarely other tumors, contain significant amounts
There is a growing body of evidence indicating that prostate-specific antigen (PSA) may be present in many steroid hormonestimulated epithelial tissues other than that of the prostate. In particular, breast tumor cell lines treated with steroid hormone receptor agonists, breast tumors, and normal hu
Background. Prostate specific antigen (PSA) is useful as a tumor marker for monitoring patients with prostate cancer after definitive therapy. Limitations have been noted when PSA was used for the early detection of prostate cancer. The use of prostate specific antigen density [PSAD = PSA (ng/ml)/pr